Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 1, 2011, Pages 40.e1-40.e8

  Caritis, Steve N ^a   Sharma, Shringi ^b   Venkataramanan, Raman ^a,b   Rouse, Dwight J ^c   Peaceman, Alan M ^d   Sciscione, Anthony ^e   Spong, Catherine Y ^p   Varner, Michael W ^f   Malone, Fergal D ^g   Iams, Jay D ^h   Mercer, Brian M ⁱ   Thorp Jr , John M ^j   Sorokin, Yoram ^k   Carpenter, Marshall ^l   Lo, Julie ^m   Ramin, Susan ⁿ   Harper, Margaret ^o  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e DREXEL UNIVERSITY   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k WAYNE STATE UNIVERSITY   (United States)

^l BROWN UNIVERSITY   (United States)

^m UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁿ UNIVERSITY OF TEXAS   (United States)

^o WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^p EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

17 hydroxyprogesterone caproate; multifetal gestation; pharmacokinetics

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ARTICLE; BLOOD SAMPLING; BODY MASS; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PRIORITY JOURNAL;

EID: 80052523645     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.03.028     Document Type: Article

References (22)

1. D.J. Rouse, S.N. Caritis, and A.M. Peaceman A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins N. Engl J Med 357 2007 454 461 (Pubitemid 47204874)
2. S.N. Caritis, D.J. Rouse, and A.M. Peaceman Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate a randomized controlled trial Obstet Gynecol 113 2009 285 292
3. C.A. Combs, T. Garite, K. Maurel, A. Das, M. Porto Obstetrix Collaborative Network Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial Am J Obstet Gynecol 203 2010 248.e1-9
4. V. Berghella, D. Figueroa, and J.M. Szychowski 17-alpha- hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length Am J Obstet Gynecol 202 2010 351.e1-6
5. S.M. Keeler, D. Kiefer, M. Rochon, J.N. Quinones, A.P. Novetsky, and O. Rust A randomized trial of cerclage vs 17-alpha-hydroxyprogesterone caproate for treatment of short cervix J Perinat Med 37 2009 473 479
6. A. Rebarber, J. Cleary-Goldman, and N.B. Istwan The use of 17 alpha-hydroxyprogesterone caproate (17P) in women with cervical cerclage Am J Perinatol 25 2008 271 275
7. S. Zhang, S.R. Mada, M. Torch, D. Mattison, S.N. Caritis, and R. Venkataramanan Simultaneous quantification of 17 alpha-hydroxyprogesterone caproate, 17 alpha-hydroxyprogesterone and progesterone in human plasma using high performance liquid chromatography-mass spectrometry (HPLC-MS/MS) J Pharm Biomed Anal 48 2008 1174 1180
8. M. Lavielle, and F. Mentre Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software J Pharmacokinet Pharmacodyn 34 2007 229 249 (Pubitemid 46536259)
9. P.L. Bonate A brief introduction to Monte Carlo simulation Clin Pharmacokinet 40 2001 15 22 (Pubitemid 32182111)
10. M. Onsrud, E. Paus, E. Huag, and K. Kjorstad Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma Acta Obstet Gynecol Scand 64 1985 519 523 (Pubitemid 15241030)
11. S. Sharma, J. Ou, and S. Strom Identification of enzymes involved in the metabolism of 17α-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth Drug Metab Dispos 36 2008 1896 1902
12. S.N. Caritis, R. Venkataramanan, M. Cotroneo, M. Smith, J.P. Chiao, and K. Habucky Pharmacokinetics and pharmacodynamics of ritodrine after intramuscular administration of pregnant women Am J Obstet Gynecol 162 1990 1215 1219 (Pubitemid 20174042)
13. S.N. Caritis, R. Venkataramanan, M.J. Darby, J.P. Chiao, and M. Krew Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen Am J Obstet Gynecol 162 1990 429 437 (Pubitemid 20068512)
14. The American Congress of Obstetricians and Gynecologists Use of progesterone to reduce preterm birth: ACOG committee opinion no. 419 October 2008 (replaces no. 291, November 2003) http://www.acog.org/publications/ committee-opinions/co419.cfm Accessed May 3, 2011
15. J.M. O'Brien, C.D. Adair, and D.F. Lewis Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial Ultrasound Obstet Gynecol 30 2007 687 696 (Pubitemid 47612689)
16. P.J. Meis, M. Klebanoff, and E. Thom Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385 (Pubitemid 36682816)
17. B.J. Attardi, A. Zeleznik, and H. Simhan Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins Am J Obstet Gynecol 197 2007 599.e1-7
18. L.M. Foglia, D.L. Ippolitio, J.D. Stallings, C.M. Zelig, and P.G. Napolitano Intramuscular 17-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells Am J Obstet Gynecol 203 2010 561.e1-5
19. S. Patel, A. Li, and T.M. Goodwin Effect of 17-alpha hydroxyprogesterone caproate on the production of tumor necrosis factor-alpha and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants J Perinatol 30 2010 584 589
20. M.A. Klebanoff, P.J. Meis, and M.P. Dombrowski Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo Am J Obstet Gynecol 199 2008 506.e1-7
21. F. Facchinetti, G. Dante, P. Venturini, S. Paganelli, and A. Volpe 17alpha-hydroxyprogesterone effects on cervical proinflammatory agents in women at risk for preterm delivery Am J Perinatol 25 2008 503 506
22. G.M. Tiboni, A. Del Corso, and F. Marotta Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse In Vivo 22 2008 447 450